These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30551512)

  • 1. The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.
    Hassan M; Raza H; Abbasi MA; Moustafa AA; Seo SY
    Biomed Pharmacother; 2019 Jan; 109():2513-2526. PubMed ID: 30551512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.
    Hassan M; Yasir M; Shahzadi S; Kloczkowski A
    ACS Omega; 2022 Jun; 7(23):19243-19260. PubMed ID: 35721972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.
    Hassan M; Shahzadi S; Yasir M; Chun W; Kloczkowski A
    Sci Rep; 2023 Oct; 13(1):18022. PubMed ID: 37865690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study.
    Mateev E; Kondeva-Burdina M; Georgieva M; Zlatkov A
    J Mol Graph Model; 2023 Jul; 122():108471. PubMed ID: 37087882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.
    Rizvi SM; Shaikh S; Naaz D; Shakil S; Ahmad A; Haneef M; Abuzenadah AM
    Neurochem Res; 2016 Jun; 41(6):1475-82. PubMed ID: 26886763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking, synthesis and biological evaluation of phenacyl derivatives of 9-aminoacridine as anti-Alzheimer's agent.
    Munawar R; Mushtaq N; Ahmad A; Saeed SMG; Usmani S; Akhtar S; Saify ZS; Arif M; Akram A
    Pak J Pharm Sci; 2020 Mar; 33(2):659-668. PubMed ID: 32276912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing for Alzheimer's disease:
    Kumar N; Gahlawat A; Kumar RN; Singh YP; Modi G; Garg P
    J Biomol Struct Dyn; 2022 Apr; 40(7):2878-2892. PubMed ID: 33170091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
    Dhanjal JK; Sharma S; Grover A; Das A
    Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals.
    Amat-Ur-Rasool H; Ahmed M
    PLoS One; 2015; 10(9):e0136509. PubMed ID: 26325402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.
    Mao F; Wang H; Ni W; Zheng X; Wang M; Bao K; Ling D; Li X; Xu Y; Zhang H; Li J
    ACS Chem Neurosci; 2018 Feb; 9(2):328-345. PubMed ID: 29068218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evaluation of herbal compounds as potent inhibitors of acetylcholinesterase for the treatment of Alzheimer's disease.
    Chen YX; Li GZ; Zhang B; Xia ZY; Zhang M
    Mol Med Rep; 2016 Jul; 14(1):446-52. PubMed ID: 27176468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry.
    Bagri K; Kumar A; Manisha ; Kumar P
    Mini Rev Med Chem; 2020; 20(14):1403-1435. PubMed ID: 31884928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
    Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
    J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity.
    Pan H; Zhang J; Wang Y; Cui K; Cao Y; Wang L; Wu Y
    Life Sci; 2019 Apr; 222():112-116. PubMed ID: 30802512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS; Wang XB; Hu XJ; Kong LY
    Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.